GI/endoscopy company stock report – Feb. 6, 2015

Here is a stock report on five publicly traded GI/endoscopy companies for Feb. 2 to Feb. 6.

Advertisement

•    AbbVie: $57.26 per share (down 1.26 percent)
•    Boston Scientific: $15.14 per share (up 0.7 percent)  
•    FUJIFILM Holdings: 3,981 per share (JPY) (up 0.49 percent)
•    Olympus: 4,125 per share (JPY) (up 2.74 percent)
•    Salix Pharmaceuticals: $142.17 per share (up 0.67 percent)

More articles on gastroenterology:
6 gastroenterologists serving as CMOs
New drugs, screening tactics could nearly eliminate HCV by 2036
Preparing for potential GI payment cuts: 3 quick tips

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.